Literature DB >> 9151838

Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein.

M Huang1, M A Martin.   

Abstract

The determinants critical for the incorporation of Pr160(gag-pol) into human immunodeficiency virus type 1 (HIV-1) particles were examined by cotransfecting cells with (i) a plasmid expressing wild-type Gag protein and (ii) a series of chimeric Gag-Pol expression plasmids in which individual murine leukemia virus (MLV) Gag regions and subdomains precisely replaced their HIV-1 counterparts. The presence of the MLV MA and NC Gag regions in the chimeric Gag-Pol precursor had no detectable effect on the incorporation of Gag-Pol into progeny virions. In contrast, the entire HIV-1 CA region was required to achieve wild-type levels of Gag-Pol assembly into particles; both the CA major homology region and the adjacent C-terminal CA sequences play dominant roles in this process yet, when assayed in the context of a chimeric Gag-Pol polyprotein, restored the defect affecting Gag-Pol incorporation to approximately half of the wild-type level.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151838      PMCID: PMC191666     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Form, function, and use of retroviral gag proteins.

Authors:  J W Wills; R C Craven
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

2.  Lack of integrase can markedly affect human immunodeficiency virus type 1 particle production in the presence of an active viral protease.

Authors:  A Bukovsky; H Göttlinger
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

3.  Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells.

Authors:  K Mergener; M Fäcke; R Welker; V Brinkmann; H R Gelderblom; H G Kräusslich
Journal:  Virology       Date:  1992-01       Impact factor: 3.616

4.  Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.

Authors:  A J Smith; N Srinivasakumar; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

5.  Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation.

Authors:  A von Poblotzki; R Wagner; M Niedrig; G Wanner; H Wolf; S Modrow
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

6.  Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus-infected cells.

Authors:  M Royer; S S Hong; B Gay; M Cerutti; P Boulanger
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.

Authors:  V Karacostas; E J Wolffe; K Nagashima; M A Gonda; B Moss
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

8.  The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Isolation of defective mutant of avian sarcoma virus.

Authors:  S Kawai; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

10.  Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.

Authors:  J Park; C D Morrow
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

View more
  25 in total

1.  Role of RNA in facilitating Gag/Gag-Pol interaction.

Authors:  Ahmad Khorchid; Rabih Halwani; Mark A Wainberg; Lawrence Kleiman
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.

Authors:  M K Hill; C W Hooker; D Harrich; S M Crowe; J Mak
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Ty3 capsid mutations reveal early and late functions of the amino-terminal domain.

Authors:  Liza S Z Larsen; Min Zhang; Nadejda Beliakova-Bethell; Virginia Bilanchone; Anne Lamsa; Kunio Nagashima; Rani Najdi; Kathryn Kosaka; Vuk Kovacevic; Jianlin Cheng; Pierre Baldi; G Wesley Hatfield; Suzanne Sandmeyer
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

4.  Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.

Authors:  S Sei; Q E Yang; D O'Neill; K Yoshimura; K Nagashima; H Mitsuya
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Coding sequences upstream of the human immunodeficiency virus type 1 reverse transcriptase domain in Gag-Pol are not essential for incorporation of the Pr160(gag-pol) into virus particles.

Authors:  Hsu-Chen Chiu; Szu-Yung Yao; Chin-Tien Wang
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

6.  Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release.

Authors:  C T Wang; H Y Lai; J J Li
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.

Authors:  M Dettenhofer; X F Yu
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.

Authors:  Chien-Cheng Chiang; Shiu-Mei Wang; Yen-Yu Pan; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

10.  Determinants of Moloney murine leukemia virus Gag-Pol and genomic RNA proportions.

Authors:  Silas F Johnson; John T Collins; Victoria M D'Souza; Alice Telesnitsky
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.